α-tocopheryl quinone is converted into vitamin E in man

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/S0891-5849(96)00276-6
AuthorSearch for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada
FormatText
TypeArticle
Journal titleFree Radical Biology and Medicine
ISSN0891-5849
Volume22
Issue5
Pages931–934; # of pages: 4
Subjectalpha tocopherol; alpha tocopherylquinone; free radical; anticoagulant therapy; article; drug blood level; drug effect; drug transformation; heart infarction; human; priority journal; stroke; Administration, Oral; Aged; Biotransformation; Gas Chromatography-Mass Spectrometry; Humans; Intestinal Absorption; Male; Vitamin E
Abstract
The conversion of α-tocopheryl quinone into α-tocopherol in humans has been demonstrated. A male subject was given an oral dose of 400 mg of α- 3,5-[(C2H3)2]-tocopheryl quinone with an evening meal. Analysis of plasma 15 h later by lipid extraction and subsequent GC-MS single ion monitoring revealed the presence of α-[5,7(C2H3)2]-tocopherol at a concentration of 0.4 μM, representing 0.8% of the total tocopherol in the plasma sample. This experiment clearly demonstrates that orally administered α tocopheryl quinone is converted in a low overall yield to α-tocopherol in humans. The conversion to α-tocopherol of that portion of the quinone dose which was actually absorbed into the blood stream may, however, have been fairly efficient.
Publication date
LanguageEnglish
Peer reviewedYes
NPARC number21276524
Export citationExport as RIS
Report a correctionReport a correction
Record identifier12bc1697-913c-47d8-998b-62a1513a6c78
Record created2015-10-13
Record modified2016-05-09
Date modified:
Report a problem on this page